Our Goal
We are on a mission to improve availability, reliability and sustainability of generic medicines. Located at the Leiden Bio Science Park, the Netherlands, we drive innovation in the generics industry together with our partners.
In our work, we are committed to meeting the evolving needs of our clients by using our experience and expertise to always deliver the best possible services.
Our Services
We drive innovation in the generics industry
to become better, more reliable and more sustainable.
Purpose
We all wish to enjoy healthy lives. Sometimes, illness interferes with our ambition.
This is where our work can make a difference: Our purpose is to help patients feel stronger and get better.
We do this by delivering high-quality medicines and services: reliable, affordable and sustainable.
Innovation
We are convinced that innovation is the key to become better and do better. Through innovation we can solve many of today’s healthcare challenges.
Knowledge preservation and maintaining production of generic medicine in the European Union is vital for this.
We are located at the Leiden Bio Science Park, the Netherlands, and engage with stakeholders and partners to drive innovation in the generics industry.
We actively pioneer new tabletting technologies. We support Dutch academia, knowledge centres and other stakeholders in knowledge building and preservation.
Latest news and stories
We zijn gestart
We zijn ongelofelijk blij, trots en dankbaar dat een belangrijke generieke geneesmiddelenfabrikant van Nederland dankzij de volhardendheid van al onze partners deze week een nieuwe start mag maken onder de vlag van InnoGenerics.
European Commission approves government loan to support largest Dutch drugs maker
The European Commission (EC) has given the Dutch Government approval to support us! We are grateful and feel doubly supported (!) in our mission to
Cabinet gives drug factory state aid to prevent dependence on foreign countries
Partly because of experiences in the corona crisis, the cabinet is preventing the large Apotex drug factory from having to close. The company is restarting
Cabinet lends millions to company to acquire drug manufacturer Apotex
The cabinet is lending 6.7 million euros to the company InnoGenerics B.V. so that Apotex, the only pharmaceutical manufacturer in the Netherlands, can remain open.
Start-up saves largest pharmaceutical manufacturer in the Netherlands
The more than 100-year-old pharmaceutical factory of Apotex Leiden is getting a restart. This will prevent the factory, which is still in Indian hands, from
Cabinet comes to the rescue with the restart of the Apotex pharma factory
Closure of the company’s factory in Leiden has been prevented, partly due to a loan from the cabinet. The Apotex drug factory in Leiden, threatened
EN 
NL